This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Irimajiri Therapeutics Inc., Epo-Med Inc., Oita University Institute of Advanced Medicine, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
1 out of 1 
1 out of 1 Years Active: 2022-2025
Title: Akira Katoh: Innovator in Pharmaceutical Compounds
Introduction
Akira Katoh is a notable inventor based in Yufu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of various diseases. With a total of 4 patents to his name, Katoh's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents, Katoh has developed cyclic amide compounds aimed at treating and preventing rabies. This patent outlines compounds represented by specific formulas, which are designed to be used in pharmaceutical compositions for rabies treatment. Additionally, he has created an anti-erythropoietin receptor peptide, which includes a detailed structure that may have therapeutic applications.
Career Highlights
Throughout his career, Akira Katoh has worked with various companies, including Irimajiri Therapeutics Inc. and Epo-Med Inc. His innovative approaches and research have contributed to advancements in pharmaceutical science.
Collaborations
Katoh has collaborated with notable individuals in his field, including Shigeru Matsuoka and Tadashi Mishina. These partnerships have likely enhanced the scope and impact of his research.
Conclusion
Akira Katoh's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a dedication to developing effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile